|
IN184589B
(hu)
*
|
1996-10-16 |
2000-09-09 |
Alza Corp |
|
|
US20020182258A1
(en)
*
|
1997-01-22 |
2002-12-05 |
Zycos Inc., A Delaware Corporation |
Microparticles for delivery of nucleic acid
|
|
US7258869B1
(en)
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
|
AU2046101A
(en)
*
|
1999-11-22 |
2001-06-04 |
Universal Preservation Technologies, Inc. |
Preservation and formulation of bioactive materials for storage and delivery in hydrophobic carriers
|
|
US7456009B2
(en)
*
|
2000-03-07 |
2008-11-25 |
Merck & Co., Inc. |
Adenovirus formulations
|
|
JP5118798B2
(ja)
*
|
2000-03-07 |
2013-01-16 |
メルク・シャープ・エンド・ドーム・コーポレイション |
アデノウイルス製剤
|
|
US7153472B1
(en)
|
2000-11-22 |
2006-12-26 |
Quadrant Drug Delivery Limited |
Preservation and formulation of bioactive materials for storage and delivery in hydrophobic carriers
|
|
US6827250B2
(en)
*
|
2001-06-28 |
2004-12-07 |
Microchips, Inc. |
Methods for hermetically sealing microchip reservoir devices
|
|
WO2003048665A1
(en)
|
2001-12-03 |
2003-06-12 |
Massachusetts Institute Of Technology |
Microscale lyophilization and drying methods for the stabilization of molecules
|
|
AU2003233396B2
(en)
*
|
2002-03-13 |
2007-05-24 |
Thomas Skold |
Water-based delivery systems
|
|
JP4436258B2
(ja)
*
|
2002-08-16 |
2010-03-24 |
マイクロチップス・インコーポレーテッド |
制御された放出デバイスおよび方法
|
|
US7497855B2
(en)
*
|
2002-09-04 |
2009-03-03 |
Microchips, Inc. |
Method and device for the controlled delivery of parathyroid hormone
|
|
CA2500215C
(en)
*
|
2002-09-27 |
2012-02-28 |
Powderject Research Limited |
Nucleic acid coated particles
|
|
US7599737B2
(en)
|
2002-10-04 |
2009-10-06 |
Microchips, Inc. |
Medical device for neural stimulation and controlled drug delivery
|
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
|
JP5591434B2
(ja)
|
2002-12-20 |
2014-09-17 |
ゼリス ファーマシューティカルズ インコーポレイテッド |
皮内注射方法
|
|
US8084424B2
(en)
*
|
2003-04-09 |
2011-12-27 |
University Of Utah Research Foundation |
Compositions and methods related to erythropoietin
|
|
ATE494885T1
(de)
*
|
2003-04-25 |
2011-01-15 |
Boston Scient Scimed Inc |
Feste arzneimittelformulierung und vorrichtung zu ihrer aufbewahrung und kontrollierten abgabe
|
|
US7892205B2
(en)
|
2003-06-06 |
2011-02-22 |
Boston Scientific Scimed, Inc. |
Device and method for delivering micronized therapeutic agents in the body
|
|
DE602004029396D1
(de)
*
|
2003-11-03 |
2010-11-11 |
Microchips Inc |
Medizinprodukt zum messen von glucose
|
|
US20050267440A1
(en)
*
|
2004-06-01 |
2005-12-01 |
Herman Stephen J |
Devices and methods for measuring and enhancing drug or analyte transport to/from medical implant
|
|
US7537590B2
(en)
*
|
2004-07-30 |
2009-05-26 |
Microchips, Inc. |
Multi-reservoir device for transdermal drug delivery and sensing
|
|
US20060029551A1
(en)
*
|
2004-08-05 |
2006-02-09 |
Kui Liu |
Stable particle formulations of erythropoietin receptor agonists
|
|
US7772182B2
(en)
*
|
2004-08-05 |
2010-08-10 |
Alza Corporation |
Stable suspension formulations of erythropoietin receptor agonists
|
|
EP1791643B1
(en)
*
|
2004-09-01 |
2009-03-11 |
Microchips, Inc. |
Multi-cap reservoir devices for controlled release or exposure of reservoir contents
|
|
WO2006031500A2
(en)
*
|
2004-09-10 |
2006-03-23 |
Becton, Dickinson And Company |
Reconstituting infusion device
|
|
WO2006081279A2
(en)
|
2005-01-25 |
2006-08-03 |
Microchips, Inc. |
Control of drug release by transient modification of local microenvironments
|
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
|
AU2006330526B2
(en)
*
|
2005-12-22 |
2012-09-27 |
Oakwood Laboratories, Llc |
Sublimable sustained release delivery system and method of making same
|
|
CA2651855C
(en)
|
2006-05-30 |
2011-08-02 |
Intarcia Therapeutics, Inc. |
Two-piece, internal-channel osmotic delivery system flow modulator
|
|
ES2422864T3
(es)
|
2006-08-09 |
2013-09-16 |
Intarcia Therapeutics, Inc |
Sistemas de liberación osmótica y unidades de pistón
|
|
MX2009010405A
(es)
*
|
2007-03-30 |
2010-02-03 |
Helix Biopharma Corp |
Composicion en vesicula de lipido bifasico y metodo para tratar la displasia cervical mediante suministro intravaginal.
|
|
PT2157967E
(pt)
|
2007-04-23 |
2013-04-03 |
Intarcia Therapeutics Inc |
Formulações de suspensões de péptidos insulinotrópicos e suas utilizações
|
|
DK2170283T3
(en)
|
2007-06-22 |
2019-04-15 |
Univ Texas |
CREATION OF STABLE SUBMICRON Peptide OR PROTEIN PARTICLES BY THIN FILM FREEZING
|
|
EP2240155B1
(en)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
|
JP5711138B2
(ja)
|
2008-11-16 |
2015-04-30 |
ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム |
高濃度の低粘度懸濁液
|
|
EP2398466B1
(en)
*
|
2008-11-24 |
2021-02-17 |
Massachusetts Institute of Technology |
Methods and compositions for localized nanoparticle delivery to a tumor
|
|
KR101823699B1
(ko)
|
2009-09-28 |
2018-01-30 |
인타르시아 세라퓨틱스 인코포레이티드 |
실질 항정상태 약물 전달의 신속 확립 및/또는 종결
|
|
US9072668B2
(en)
|
2010-03-09 |
2015-07-07 |
Janssen Biotech, Inc. |
Non-aqueous high concentration reduced viscosity suspension formulations of antibodies
|
|
CN103096934A
(zh)
*
|
2010-03-09 |
2013-05-08 |
詹森生物科技公司 |
非水性高浓度低粘度混悬剂
|
|
US20110223208A1
(en)
|
2010-03-09 |
2011-09-15 |
Beth Hill |
Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations
|
|
MX2012010684A
(es)
|
2010-03-17 |
2012-11-06 |
Novaliq Gmbh |
Composicion farmaceutica para el tratamiento de la presion intraocular incrementada.
|
|
US20120046225A1
(en)
|
2010-07-19 |
2012-02-23 |
The Regents Of The University Of Colorado, A Body Corporate |
Stable glucagon formulations for the treatment of hypoglycemia
|
|
EP2444063A1
(en)
|
2010-10-20 |
2012-04-25 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the delivery of active ingredients
|
|
EP2462921A1
(en)
|
2010-11-11 |
2012-06-13 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the treatment of a posterior eye disease
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
BR112013023062B1
(pt)
|
2011-03-10 |
2022-01-18 |
Xeris Pharmaceuticals, Inc |
Solução estável para a injeção parenteral e método de fabricação da mesma
|
|
CA2834855C
(en)
|
2011-05-25 |
2020-12-29 |
Novaliq Gmbh |
Topical pharmaceutical composition based on semifluorinated alkanes
|
|
ES2617968T3
(es)
|
2011-05-25 |
2017-06-20 |
Novaliq Gmbh |
Composición farmacéutica para la administración a uñas
|
|
KR102007057B1
(ko)
|
2011-10-31 |
2019-08-02 |
엑스에리스 파머수티클스, 인크. |
당뇨병 치료를 위한 제형물
|
|
MX361681B
(es)
|
2012-01-23 |
2018-12-13 |
Novaliq Gmbh |
Composiciones de proteína estabilizadas basadas en alcanos semifluorados.
|
|
US9125805B2
(en)
|
2012-06-27 |
2015-09-08 |
Xeris Pharmaceuticals, Inc. |
Stable formulations for parenteral injection of small molecule drugs
|
|
CA2883003C
(en)
|
2012-09-12 |
2021-11-16 |
Novaliq Gmbh |
Semifluorinated alkane compositions
|
|
ES2974663T3
(es)
|
2012-09-12 |
2024-07-01 |
Novaliq Gmbh |
Alcanos semifluorados para uso en la solubilización de meibomio
|
|
WO2014110491A1
(en)
|
2013-01-11 |
2014-07-17 |
Theratrophix Llc |
Prodrugs of treprostinil
|
|
US9505737B2
(en)
|
2013-01-11 |
2016-11-29 |
Corsair Pharma, Inc. |
Treprostinil derivative compounds and methods of using same
|
|
US9018162B2
(en)
|
2013-02-06 |
2015-04-28 |
Xeris Pharmaceuticals, Inc. |
Methods for rapidly treating severe hypoglycemia
|
|
SG11201505926VA
(en)
*
|
2013-03-15 |
2015-09-29 |
Biogen Ma Inc |
Factor ix polypeptide formulations
|
|
CA2918419C
(en)
|
2013-07-23 |
2022-05-03 |
Novaliq Gmbh |
Stabilized antibody compositions
|
|
US10159646B2
(en)
|
2013-08-12 |
2018-12-25 |
Altum-Avro Pharma Partnership |
Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
|
|
US8986732B2
(en)
|
2013-08-12 |
2015-03-24 |
Helix Biopharma Corporation |
Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
|
|
RU2675824C2
(ru)
|
2013-09-11 |
2018-12-25 |
Игл Байолоджикс, Инк. |
Жидкие белковые составы, содержащие ионные жидкости
|
|
EP3049114B1
(en)
|
2013-09-27 |
2021-11-10 |
Massachusetts Institute of Technology |
Carrier-free biologically-active protein nanostructures
|
|
EP3123090A4
(en)
*
|
2014-03-24 |
2017-12-13 |
Bioverativ Therapeutics Inc. |
Lyophilized factor ix formulations
|
|
JP6561109B2
(ja)
|
2014-07-16 |
2019-08-14 |
コルセア ファーマ インコーポレイテッド |
トレプロスチニル誘導体化合物およびその使用方法
|
|
AU2015300944B2
(en)
|
2014-08-06 |
2019-07-11 |
Xeris Pharmaceuticals, Inc. |
Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes
|
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
|
KR102497368B1
(ko)
|
2014-10-01 |
2023-02-10 |
이글 바이올로직스 인코포레이티드 |
점도-저하제를 함유하는 폴리삭카라이드 및 핵산 제형
|
|
US10925639B2
(en)
|
2015-06-03 |
2021-02-23 |
Intarcia Therapeutics, Inc. |
Implant placement and removal systems
|
|
US9649364B2
(en)
|
2015-09-25 |
2017-05-16 |
Xeris Pharmaceuticals, Inc. |
Methods for producing stable therapeutic formulations in aprotic polar solvents
|
|
US9394227B1
(en)
|
2015-06-17 |
2016-07-19 |
Corsair Pharma, Inc. |
Treprostinil derivatives and compositions and uses thereof
|
|
US9643911B2
(en)
|
2015-06-17 |
2017-05-09 |
Corsair Pharma, Inc. |
Treprostinil derivatives and compositions and uses thereof
|
|
US11034752B2
(en)
|
2015-08-12 |
2021-06-15 |
Massachusetts Institute Of Technology |
Cell surface coupling of nanoparticles
|
|
US11590205B2
(en)
|
2015-09-25 |
2023-02-28 |
Xeris Pharmaceuticals, Inc. |
Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
|
|
DK3355990T3
(da)
|
2015-09-30 |
2019-09-16 |
Novaliq Gmbh |
Semifluorinerede forbindelser og disses sammensætninger
|
|
AU2016329261B2
(en)
|
2015-09-30 |
2020-05-07 |
Novaliq Gmbh |
Semifluorinated compounds for ophthalmic administration
|
|
KR102574993B1
(ko)
|
2016-05-16 |
2023-09-06 |
인타르시아 세라퓨틱스 인코포레이티드 |
글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
|
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
|
EP3468581A1
(en)
|
2016-06-13 |
2019-04-17 |
Torque Therapeutics, Inc. |
Methods and compositions for promoting immune cell function
|
|
PT3442480T
(pt)
|
2016-06-23 |
2019-12-23 |
Novaliq Gmbh |
Método de administração tópica
|
|
MX2019003363A
(es)
|
2016-09-22 |
2019-10-02 |
Novaliq Gmbh |
Composiciones farmaceuticas para usarse en la terapia de la blefaritis.
|
|
AU2017329983B2
(en)
|
2016-09-23 |
2022-05-05 |
Novaliq Gmbh |
Ophthalmic compositions comprising ciclosporin
|
|
KR20190104039A
(ko)
|
2017-01-03 |
2019-09-05 |
인타르시아 세라퓨틱스 인코포레이티드 |
Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법
|
|
EP3612228B1
(en)
|
2017-04-21 |
2023-08-23 |
Dermaliq Therapeutics, Inc. |
Iodine compositions
|
|
US11278503B2
(en)
|
2017-05-12 |
2022-03-22 |
Novaliq Gmbh |
Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions
|
|
CA3063324A1
(en)
|
2017-05-16 |
2018-11-22 |
Bhami's Research Laboratory, Pvt. Ltd. |
High concentration protein formulations with reduced viscosity
|
|
CN110709061B
(zh)
|
2017-06-02 |
2023-09-08 |
Xeris药物公司 |
抗沉淀的小分子药物制剂
|
|
JP7285828B2
(ja)
|
2017-09-05 |
2023-06-02 |
トルク セラピューティクス， インコーポレイテッド |
治療用タンパク質組成物ならびにその作製および使用方法
|
|
JP2020535156A
(ja)
|
2017-09-27 |
2020-12-03 |
ノバリック ゲーエムベーハー |
眼疾患の治療に使用するためのラタノプロストを含む眼科用組成物
|
|
CN111182893A
(zh)
|
2017-10-04 |
2020-05-19 |
诺瓦利克有限责任公司 |
包含f6h8的眼用组合物
|
|
JP7353292B2
(ja)
|
2018-03-02 |
2023-09-29 |
ノバリック ゲーエムベーハー |
ネビボロールを含む医薬組成物
|
|
WO2019217637A1
(en)
*
|
2018-05-09 |
2019-11-14 |
Biomatrica, Inc. |
Stabilization of proteins in biological samples
|
|
JP7500550B2
(ja)
|
2018-10-12 |
2024-06-17 |
ノバリック ゲーエムベーハー |
乾性眼疾患の治療のための眼科用組成物
|
|
CN113661006A
(zh)
|
2019-02-05 |
2021-11-16 |
林迪生物科学公司 |
分离的细胞培养物组分以及用于从液体细胞培养基中分离其的方法
|
|
EP4069324A4
(en)
|
2019-12-06 |
2024-01-10 |
Guangzhou Bioseal Biotech Co., Ltd. |
FLUID FIBRINOGEN THROMBIN PASTE
|
|
WO2022109294A2
(en)
*
|
2020-11-20 |
2022-05-27 |
Team Medical Llc |
Rna stabilization
|
|
US20230101362A1
(en)
*
|
2021-09-16 |
2023-03-30 |
Team Medical Llc |
Rna stabilization
|